A Phase 1b, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Safety and Efficacy of Oral Zavegepant in Subjects With Mild Allergic Asthma
A Phase 1b, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Safety and Efficacy of Oral Zavegepant in Subjects With Mild Allergic Asthma
This study is a double-blind, parallel-group, randomized study of active drug vs placebo in asthma.
Inclusion Criteria:
Exclusion Criteria:
-
Québec, Quebec G1V 4G5, Canada